Cargando…

Arrhythmic Burden in Cardiac Amyloidosis: What We Know and What We Do Not

Cardiac amyloidosis (CA), caused by the deposition of insoluble amyloid fibrils, impairs different cardiac structures, altering not only left ventricle (LV) systo-diastolic function but also atrial function and the conduction system. The consequences of the involvement of the cardiac electrical syst...

Descripción completa

Detalles Bibliográficos
Autores principales:	Argirò, Alessia, Del Franco, Annamaria, Mazzoni, Carlotta, Allinovi, Marco, Tomberli, Alessia, Tarquini, Roberto, Di Mario, Carlo, Perfetto, Federico, Cappelli, Francesco, Zampieri, Mattia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687719/ https://www.ncbi.nlm.nih.gov/pubmed/36359408 http://dx.doi.org/10.3390/biomedicines10112888

Ejemplares similares

Prevalence of anxiety and depression symptoms in a sample of outpatients with ATTR cardiac amyloidosis
por: Smorti, Martina, et al.
Publicado: (2023)

Transthyretin Cardiac Amyloidosis: A Cardio-Orthopedic Disease
por: Perfetto, Federico, et al.
Publicado: (2022)

Circulating biomarkers in diagnosis and management of cardiac amyloidosis: a review for internist
por: Perfetto, Federico, et al.
Publicado: (2022)

The origin of life: what we know, what we can know and what we will never know
por: Pross, Addy, et al.
Publicado: (2013)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know
por: Dhawan, Rahul, et al.
Publicado: (2020)

The Economic Burden of Food Allergy: What We Know and What We Need to Learn
por: Fong, Andrew T., et al.
Publicado: (2022)

International Trade and Investment and Food Systems: What We Know, What We Don’t Know, and What We Don’t Know We Don’t Know
por: Schram, Ashley, et al.
Publicado: (2020)

“Tau Oligomers,” What We Know and What We Don’t Know
por: Sahara, Naruhiko, et al.
Publicado: (2014)

Epigenetics in Schistosomes: What We Know and What We Need Know
por: Liu, Weiwei
Publicado: (2016)

Portion Size: What We Know and What We Need to Know
por: Benton, David
Publicado: (2015)

Paediatric schistosomiasis: What we know and what we need to know
por: Osakunor, Derick N. M., et al.
Publicado: (2018)

Immunotherapy and fatigue: what we know and what we don’t know
por: Azeem Khan, Muhammad, et al.
Publicado: (2021)

Vaginal Aging—What We Know and What We Do Not Know
por: Szymański, Jacek K., et al.
Publicado: (2021)

Metabolic syndrome: what we know and what we need to know
por: Soares, Raquel
Publicado: (2020)

Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
por: Zelek, Wioleta M., et al.
Publicado: (2023)

Cutaneous Adnexal Cysts Revisited: What We Know and What We Think We Know
por: Kaya, Gürkan, et al.
Publicado: (2018)

Commentary: Is this a case in which we know what we don't know what we don't know?
por: Nantsios, Alex, et al.
Publicado: (2021)

Nephrotoxicity testing in vitro--what we know and what we need to know.
por: Pfaller, W, et al.
Publicado: (1998)

Asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

What We Know and What We Don't Know About Preventing Stroke
por: Burch, Druin
Publicado: (2014)

Contagious itch: what we know and what we would like to know
por: Schut, C., et al.
Publicado: (2015)

Goal-directed therapy: what we know and what we need to know
por: O’Neal, Jason B, et al.
Publicado: (2015)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Human Extraintestinal Sarcocystosis: What We Know, and What We don’t Know
por: Harris, V. C., et al.
Publicado: (2015)

Membrane fission by dynamin: what we know and what we need to know
por: Antonny, Bruno, et al.
Publicado: (2016)

Microplastics in freshwater ecosystems: what we know and what we need to know
por: Wagner, Martin, et al.
Publicado: (2014)

Peri-implant disease: what we know and what we need to know
por: Valente, Nicola Alberto, et al.
Publicado: (2016)

Pneumonia in Bhutanese children: what we know, and what we need to know
por: Jullien, Sophie, et al.
Publicado: (2020)

Impacts of Neonicotinoids on Molluscs: What We Know and What We Need to Know
por: Ewere, Endurance E, et al.
Publicado: (2021)

COVID-19 in Children: What We Know and What We Don’t Know?
por: Jat, Kana Ram
Publicado: (2021)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Cardiac amyloidosis and surgery: What do we know about rare diseases?
por: Mestres, Carlos A., et al.
Publicado: (2021)

Thymic neuroendocrine neoplasms—what we know, what we don’t know, and what to do about it
por: Lang, Matthias, et al.
Publicado: (2023)

Stage-specific therapy for hypertrophic cardiomyopathy
por: Argirò, Alessia, et al.
Publicado: (2023)

Erratum: asthma in the elderly: what we know and what we have yet to know
por: Yáñez, Anahí, et al.
Publicado: (2014)

Editorial: Prostate Cancer: What We Know and What We Would Like to Know
por: Taverna, Gianluigi, et al.
Publicado: (2015)

Metal wear particles: What we know, what we do not know, and why
por: Billi, Fabrizio, et al.
Publicado: (2009)

Plant hormone transporters: what we know and what we would like to know
por: Park, Jiyoung, et al.
Publicado: (2017)

Mechanisms of atrial fibrillation in athletes: what we know and what we do not know
por: Guasch, E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1f5b9hhmvsi0074h9j21g9a8lr